Vascular Endothelial Growth Factor Acts Primarily via Platelet-Derived Growth Factor Receptor α to Promote Proliferative Vitreoretinopathy

Ítems similars

• A Novel Strategy to Develop Therapeutic Approaches to Prevent Proliferative Vitreoretinopathy
  per: Pennock, Steven, et al.
  Publicat: (2011)
• Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia
  per: Pennock, Steven, et al.
  Publicat: (2016)
• Vascular Endothelial Growth Factor A Competitively Inhibits Platelet-Derived Growth Factor (PDGF)-Dependent Activation of PDGF Receptor and Subsequent Signaling Events and Cellular Responses
  per: Pennock, Steven, et al.
  Publicat: (2012)
• Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy
  per: Lei, Hetian, et al.
  Publicat: (2009)
• Proliferative vitreoretinopathy and antivascular endothelial growth factor treatment
  per: Ghasemi Falavarjani, K, et al.
  Publicat: (2014)